3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
10
Lung Neoplasms
9
Colorectal Neoplasms
7
Breast Neoplasms
7
Prostatic Neoplasms
6
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Neoplasm Metastasis
3
Colonic Neoplasms
3
Stomach Neoplasms
2
Smoking Cessation
2
Neoplastic Cells, Circulating
2
Motor Activity
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Endometrial Neoplasms
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Venous Thromboembolism
1
Vaginal Neoplasms
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Testicular Germ Cell Tumor
1
Stroke
1
Solitary Pulmonary Nodule
1
Skin Neoplasms
1
Sezary Syndrome
1
Interventions
Dexamethasone
8
Bortezomib
7
Cyclophosphamide
6
Lenalidomide
4
isatuximab
3
glucarpidase
3
Calcium Dobesilate
3
Thalidomide
2
Kidney Transplantation
2
Blood Specimen Collection
2
Bendamustine Hydrochloride
2
pomalidomide
1
gamma-Glutamyl Hydrolase
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
auricularum
1
Whole-Body Irradiation
1
Urination
1
Urinalysis
1
Stents
1
Standard of Care
1
Rituximab
1
Ranitidine
1
Nephrotomy
1
Nephrostomy, Percutaneous
1
Methotrexate
1
Leucovorin
1
Ice
1
Hematologic Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Renal Insufficiency
×
Hematologic Tests
×
Clear all
NCT04308642
2024-05-16
Kid-MaCareOnco
University Hospital, Basel, Switzerland
Completed
6 enrolled